Therapeutic silencing of miR‐652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy-Reference-Cited by-同舟云学术

Therapeutic silencing of miR‐652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy

Published:2014-08-21 Issue:12 Volume:28 Page:5097-5110
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Bernardo Bianca C.¹,Nguyen Sally S.¹²,Winbanks Catherine E.¹,Gao Xiao‐Ming¹,Boey Esther J. H.¹,Tham Yow Keat¹,Kiriazis Helen¹,Ooi Jenny Y. Y.¹,Porrello Enzo R.³,Igoor Sindhu³,Thomas Colleen J.²,Gregorevic Paul¹,Lin Ruby C. Y.⁴,Du Xiao‐Jun¹,McMullen Julie R.¹

Affiliation:

1. Baker IDI Heart and Diabetes InstituteMelbourneVictoriaAustralia

2. Department of Human BiosciencesLa Trobe UniversityBundooraVictoriaAustralia

3. School of Biomedical SciencesUniversity of QueenslandSt. LuciaQueenslandAustralia

4. Ramaciotti Centre for Genomics and School of Biotechnology and Biomolecular SciencesUniversity of New South WalesSydneyNew South WalesAustralia

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.14-253856

Reference57 articles.